EDAP TMS S.A (F:EDA) — Market Cap & Net Worth
Market Cap & Net Worth: EDAP TMS S.A (EDA)
EDAP TMS S.A (F:EDA) has a market capitalization of $132.10 Million (€112.99 Million) as of September 17, 2026. Listed on the F stock exchange, this Germany-based company holds position #18217 globally and #1695 in its home market, demonstrating a 2.35% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EDAP TMS S.A's stock price €3.48 by its total outstanding shares 37527950 (37.53 Million). Also see EDA total assets for a full breakdown of the balance sheet.
EDAP TMS S.A Market Cap History: 2015 to 2026
EDAP TMS S.A's market capitalization history from 2015 to 2026. Data shows change from $173.04 Million to $152.68 Million (-0.98% CAGR). Also see cash efficiency ratio of EDAP TMS S.A for how efficiently the company converts equity into cash flow.
EDAP TMS S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EDAP TMS S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check EDAP TMS S.A share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.68x
EDAP TMS S.A's market cap is 1.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $133.60 Million | $35.61 Million | $3.84 Million | 3.75x | 34.77x |
| 2017 | $96.52 Million | $35.75 Million | -$681.00K | 2.70x | N/A |
| 2018 | $61.86 Million | $39.18 Million | -$338.00K | 1.58x | N/A |
| 2019 | $164.97 Million | $44.91 Million | $1.51 Million | 3.67x | 109.10x |
| 2020 | $173.74 Million | $47.80 Million | -$1.96 Million | 3.63x | N/A |
| 2021 | $201.82 Million | $44.07 Million | $700.00K | 4.58x | 288.32x |
| 2022 | $447.52 Million | $55.11 Million | -$2.93 Million | 8.12x | N/A |
| 2023 | $204.45 Million | $66.79 Million | -$23.41 Million | 3.06x | N/A |
| 2024 | $89.50 Million | $69.40 Million | -$20.58 Million | 1.29x | N/A |
| 2025 | $118.46 Million | $70.53 Million | -$29.25 Million | 1.68x | N/A |
Competitor Companies of EDA by Market Capitalization
Companies near EDAP TMS S.A in the global market cap rankings as of September 17, 2026. Review EDA tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to EDAP TMS S.A by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #249 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #541 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #642 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1204 globally with a market cap of $21.56 Billion USD ( AU$30.48 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #249 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $899.56 |
| #541 | Cencora Inc. | NYSE:COR | $50.53 Billion | $323.29 |
| #642 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $232.65 |
| #1204 | Sigma Healthcare Ltd | AU:SIG | $21.56 Billion | AU$2.64 |
EDAP TMS S.A Historical Marketcap From 2015 to 2026
Between 2015 and today, EDAP TMS S.A's market cap moved from $173.04 Million to $ 152.68 Million, with a yearly change of -0.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €152.68 Million | +28.89% |
| 2025 | €118.46 Million | +32.35% |
| 2024 | €89.50 Million | -56.22% |
| 2023 | €204.45 Million | -54.31% |
| 2022 | €447.52 Million | +121.74% |
| 2021 | €201.82 Million | +16.16% |
| 2020 | €173.74 Million | +5.32% |
| 2019 | €164.97 Million | +166.67% |
| 2018 | €61.86 Million | -35.91% |
| 2017 | €96.52 Million | -27.75% |
| 2016 | €133.60 Million | -22.79% |
| 2015 | €173.04 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of EDAP TMS S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $132.10 Million USD |
| MoneyControl | $132.10 Million USD |
| MarketWatch | $132.10 Million USD |
| marketcap.company | $132.10 Million USD |
| Reuters | $132.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About EDAP TMS S.A
EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.… Read more